Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo.
about
The interplay between Epstein-Barr virus and the immune system: a rationale for adoptive cell therapy of EBV-related disordersBurkitt lymphoma: pathogenesis and immune evasion.Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes.Epstein-Barr virus-associated lymphomas.Burkitt's lymphoma: the Rosetta Stone deciphering Epstein-Barr virus biology.Elevation of c-MYC disrupts HLA class II-mediated immune recognition of human B cell tumorsDistinct memory CD4+ T-cell subsets mediate immune recognition of Epstein Barr virus nuclear antigen 1 in healthy virus carriers.Epstein-barr virus: environmental trigger of multiple sclerosis?Autophagy in innate and adaptive immunity against intracellular pathogens.Generating functional CD8+ T cell memory response under transient CD4+ T cell deficiency: implications for vaccination of immunocompromised individuals.CD4 T cell responses in latent and chronic viral infections.CD4+ and CD8+ T-cell responses to latent antigen EBNA-1 and lytic antigen BZLF-1 during persistent lymphocryptovirus infection of rhesus macaquesFighting Viral Infections and Virus-Driven Tumors with Cytotoxic CD4+ T Cells.Role of CD4+ cytotoxic T lymphocytes in the control of viral diseases and cancer.Adoptive cellular therapy with T cells specific for EBV-derived tumor antigens.Epstein-Barr virus nuclear antigen 1-specific CD4+ T cells directly kill Epstein-Barr virus-carrying natural killer and T cells.Expression, purification, and immunogenic characterization of Epstein-Barr virus recombinant EBNA1 protein in Pichia pastoris.The clinicopathologic spectrum of mature aggressive B cell lymphomas.Epstein-Barr Virus as a Promising Immunotherapeutic Target for Nasopharyngeal Carcinoma Treatment.Lack of ex vivo peripheral and intrahepatic α-fetoprotein-specific CD4+ responses in hepatocellular carcinoma.Clinical methods of cryopreservation for donor lymphocyte infusions vary in their ability to preserve functional T-cell subpopulations.
P2860
Q34166602-F37DFCF1-F233-4CFB-B31B-BC5E1ADE2EC2Q34189497-54A358C4-6956-4672-A44F-8A2FA0D30E4DQ34593324-D1F04714-5B1A-43D2-8225-63FF9B98CB9FQ34651670-E6118905-480B-4446-83D5-9BAA1061F978Q34658852-6467C469-5F67-4D93-A51F-5FD8C1B6EBC6Q35071179-3DC67ADD-E700-43CF-8CD6-C1A24D44DB29Q35616090-0EF8FD83-EBBD-498B-8896-DA120EA50BEDQ35914342-1833FEF0-1E1C-4773-922B-E6E243DB829EQ36406535-73E6EB45-9297-479E-A0BD-516636D8A407Q36782485-BCC266C1-B8BB-447B-8C76-92A21B00F607Q36837631-9092C09C-29FE-4D26-898C-F4CD1065E6E4Q37036688-EC9D289D-C618-4791-8313-ED23979149A4Q37667998-48B56E4B-B416-474D-926C-408A6A6FB40FQ37773234-2FC50F5C-6798-4896-9022-B734E9FA1C21Q38570061-20DC57AD-1320-4D8E-88D2-4FE7D596B301Q39946166-C24C5BF5-0E4A-4F50-BA48-5E863D554396Q45351171-69A3C878-A979-4825-85CA-264A7276F4B0Q48170832-AE87AA91-5461-4EDC-8B8F-258EC2767FE0Q49787173-19927B65-EC41-46A1-ACB6-7D22B55403EDQ51026567-FD26B6D1-E9A7-4844-853B-0A53EE49183FQ52774309-46B4FC5E-884A-4BF8-8571-1673080FA2C1
P2860
Critical role of EBNA1-specific CD4+ T cells in the control of mouse Burkitt lymphoma in vivo.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Critical role of EBNA1-specifi ...... ouse Burkitt lymphoma in vivo.
@en
Critical role of EBNA1-specifi ...... ouse Burkitt lymphoma in vivo.
@nl
type
label
Critical role of EBNA1-specifi ...... ouse Burkitt lymphoma in vivo.
@en
Critical role of EBNA1-specifi ...... ouse Burkitt lymphoma in vivo.
@nl
prefLabel
Critical role of EBNA1-specifi ...... ouse Burkitt lymphoma in vivo.
@en
Critical role of EBNA1-specifi ...... ouse Burkitt lymphoma in vivo.
@nl
P2093
P2860
P356
P1476
Critical role of EBNA1-specifi ...... ouse Burkitt lymphoma in vivo.
@en
P2093
Kui Shin Voo
Rong-Fu Wang
P2860
P304
P356
10.1172/JCI22053
P407
P577
2004-08-01T00:00:00Z